25 Stock Top Picks and 4 ETF (Jan 4-10)

One of the major chip maker names to consider for your portfolio. Adds value to the supply chain.

Trades at 30x earnings, but it's warranted. Part of a duopoly, and has branched out into analytic services from its core business. Benefits from switching from cash to digital. Huge moat. There will always be regulatory risk. Happy to hold.

It's hoping to win more contracts as well as benefit from AI. Every single company is trying to implement AI into their products. Slow-growing business, more acquisition-based. Hasn't knocked it out of the park. A quite reasonable valuation. Actively looking at, would love to buy on a material pullback.

Great company. Looking at the chart, big wall of resistance it just couldn't get through. Then it broke out. If you own it, hold. If it pulls back to the neckline, he'd be all over it.

(A Top Pick Jan 08/19, Up 13%) We are starting to see a bit of a recovery in the oil price and in the demand. This is an interesting company to watch.

It has broken its support resistance at $20 and the previous resistance at $30. If it forms a base then that might be a time to buy.

Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research. KEL has strong drilling activity and currently no debt. We have KEL in the growth model portfolio, and we like it for its diversification benefits, being in the oil and gas sector. It is a strong name with a good balance sheet and healthy profit…

Excellent asset base - very had to replicate. Consistent dividend increases. Cheap valuation given cash flow abilities. Company will perform well regardless of economy. Has a long history of quality dividends. Portfolio of growth projects for the next 5 years. 

ETF recommendation? There are a number of them out there. The ones he uses add diversification and are used primarily as a short term trading vehicle for him. He mostly uses SOXX, IGV and FDN.

(A Top Pick Jul 31/24, Up 2%) It is moving in a range. It is close enough to the bottom of the range and he is tight with discipline. If it breaks its support level and stays there for a number of days, then he will sell.

Above $35, has sold all exposure to AMLP. Closer to $30, it is a good place to enter for a trade. Probably will do well buying dips and selling rallies in the near term. Maximum upside is probably $40. Long term, there are some challenges.

Making RSI new lows versus the market. Avoid this whole neighbourhood for a while.

It reports Tuesday. The CEO is an amazing salesman and he bets he will tell a good story that his movie chain is doing very well.

Password-sharing crackdown in the works. Happy with results this morning. Increased profitability from streaming. Struggling lower- and mid-income consumer impacting park revenues; probably a short-term concern. Phenomenal content library.

Today they reported a strong earnings ebay. Corporate events are up 8%, showing that business travel is coming back. Shares jumped 10% today.

(A Top Pick Jul 18/22, Up 7%) Expecting further growth of travel.Poor winter conditions impacting share price.Very strong assets with best ski hills in the business.Strong free cash flow with steady dividend.Good value proposition with season's pass.Stock price currently undervalued - good time to buy. 

Very strong brand name with growing footprint in USA. Excellent price to value proposition on the stock markets. Recent meeting with CEO very positive. Share price below pre Covid-19 levels. Expecting 8-10 new stores in the US annually. Earnings projected to grow with expanded margins. EPS growth also projected to rise as more sales roll…

They report tomorrow. Lower interest rates will push sales, and the extreme weather is behind us.

They defied even his own skepticism. They delivered a remarkable quarter: renewed strength from Asia, helped by stimulus in China. They lead in cruises.

Likes the upside potential with strong dividend (downside protection). Yield curve has smooth out - interest rates also falling. Very strong balance sheet with high lending capabilities. Company moving toward reducing global presence - capitalize on the USA. Less regulation under Trump presidency will also help company. 

Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research BNS continues to pay a solid dividend yield of 5.4%, and it is up 22% on a year-to-date basis, and 29% on a one-year basis. Its earnings outlook is improving, and most analyst estimates are trending higher recently. Analysts have been upping their price targets…

Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research We think the discussion of BAM moving its head office to the US has helped, as it has been undervalued relative to US peers. This is why the company split in the first place, so it is good that the move has worked so well.…

It has come way down with the money laundering scandal. It decided what it will pay but the stock dropped again so it has been doubly punished. Now trading below 10X - the valuation and dividend are OK. Has a new CEO and will manage the U.S. situation OK so could be fine over time.…

It's often been a trap and they mismanaged the attempted takeover of Time Warner. They are paying off debt and showing signs of grow (i.e. subscriptions). Shares and dividend are okay, but not exciting. He's neutral on this.

(A Top Pick Jul 31/18, Up 10%) A core name, still likes it and they own it. Industrial gas company, everything from oxygen for hospital to hydrogen needed to refine oil. Made a major acquisition in the U.S in 2016, heavily weigthed to the U.S. Reports in Euros so it uses U.S dollar strength to…

Higher costs thwarted profitability. Move on.

(A Top Pick Jan 29/24, Up 22%) QB2 will be a very valuable asset. Always bumps getting a new mine underway, but outlook for copper long term is very positive. Biggest risk to portfolios is that inflation eats your money, so you need to own things that can put up prices tomorrow if inflation goes…

Pharma companies are always facing the patent wall, needing to spend R&D to innovate new drugs. Very difficult to predict the next blockbuster. He prefers and owns JNJ and ABT, as they're more diversified.

Strong company that has been under owned lately. Recent quarterly earnings not as good as expected. Working capital and supply chain issues also concerning. Riskier name given lately results. Would not buy at this time.